Term Gallery logo

Significats de bladder carcinoma en anglès

Urinary bladder cancer that has material basis in abnormally proliferating cells derives from epithelial cells.

Ús de bladder carcinoma en anglès
1
Studies on HER-2 expression in bladder carcinoma have shown heterogeneous results.
Pubmed
2
Brachytherapy has a key role to play in the treatment of bladder carcinoma.
Pubmed
3
Pathologic examination showed similar histologic and immunohistochemical characteristics as the primary bladder carcinoma.
Pubmed
4
Purpose: We report the presentation of brain metastases from bladder carcinoma.
Pubmed
5
Results: Brain metastases from bladder carcinoma were commonly accompanied by uncontrolled systemic metastases.
Pubmed
6
Conclusions: Overall survival after brain metastasis development in patients with bladder carcinoma was poor.
Pubmed
7
However, the mechanisms responsible for angiogenesis in urinary bladder carcinoma patients are not well defined.
Pubmed
8
The in vitro proliferation of both bladder carcinoma cell lines was also inhibited by TNP-470.
Pubmed
9
However, no ultrasonic enhancement of doxorubicin growth inhibition in these human bladder carcinoma cells was observed.
Pubmed
10
The data indicated that ARCON could achieve a therapeutic gain in patients with advanced bladder carcinoma.
Pubmed
11
Photochemotherapy of bladder carcinoma in situ still constitutes a complex treatment protocol reserved for specialized centres.
Pubmed
12
Background: The clinical behavior of the tumor in patients with locally advanced bladder carcinoma is unpredictable.
Pubmed
13
Conclusion: This study indicates thatΔNp63 gene down-expression can reduce the invasion of bladder carcinoma cells in vitro.
Pubmed
14
Computed tomography showed diffuse, circumferential, irregular, and lobulated thickening of the bladder wall suggestive of urinary bladder carcinoma.
Pubmed
15
These data identify distinct regions of loss on chromosome 4 potentially involved in the late progression of bladder carcinoma.
Pubmed
16
Conclusions: These findings indicate that TD mutations in the FGFR3 gene do not cause disease progression of bladder carcinoma.
Pubmed